Ann: PromarkerD to feature at world's largest diabetes conference, page-6

http://www.scoop.co.nz/stories/WO1906/S00044/promarkerd-features-at-ada-79th-scientific-sessions.htm

"PromarkerD is world-beating technology and needs to get into the hands of specialists and physicians to stem the tsunami of kidney disease which is causing over 40,000 deaths per year in the US, with related healthcare spending exceeding US$100 billion annually," commented Dr Lipscombe.

"There is nothing else like PromarkerD available - it's the world's leading predictive test for diabetic kidney disease according to analysts in our sector.

"He said the test will also make a major difference for insurance companies because it will cut dramatically the number of people who are unaware they have progressive kidney disease so they can do something about it immediately, and so reduce treatments costs.

"The US population with diabetes deserve to know their kidney disease status.

"There are approximately 260,000 CLIA certified laboratories in the US, the majority of which have diagnostic capabilities to license the PromarkerD test.

PromarkerD has been rated the world's leading diagnostic test for diabetic kidney disease by global research house Frost & Sullivan in its independent industry report titled 'Biomarkers Enabling Diabetes and Obesity Management.

'PromarkerD has received patent protection in several major jurisdictions including the USA, China, Europe, and Japan, with others pending.